Eudragit RL100 nanoparticle system for the ophthalmic delivery of cloricromene

Journal of Pharmacy and Pharmacology

Volumn 56, Issue 7, 2004, Pages 841-846

  Bucolo, Claudio ^b   Maltese, Adriana ^b   Maugeri, Francesco ^b   Busà, Barbara ^a   Puglisi, Giovanni ^a   Pignatello, Rosario ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b Bausch and Lomb Oftal   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE; AGENTS ACTING ON THE EYE; CLORICROMEN; COPOLYMER; DRUG CARRIER; EUDRAGIT; FLURBIPROFEN; IBUPROFEN; LIPOSOME; METHACRYLIC ACID DERIVATIVE; NANOPARTICLE; NONSTEROID ANTIINFLAMMATORY AGENT; POLY(METHYL METHACRYLATE);

ANIMAL EXPERIMENT; AQUEOUS HUMOR; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DISPERSION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MECHANISM; DRUG RELEASE; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TISSUE LEVEL; HYDROGEL; IN VITRO STUDY; MALE; NONHUMAN; PARTICLE SIZE;

ACRYLIC RESINS; ANIMALS; AREA UNDER CURVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMONAR; DRUG ADMINISTRATION ROUTES; DRUG DELIVERY SYSTEMS; DRUG STABILITY; MALE; NANOTECHNOLOGY; PARTICLE SIZE; PLATELET AGGREGATION INHIBITORS; RABBITS; SOLUBILITY; SURFACE PROPERTIES; TECHNOLOGY, PHARMACEUTICAL;

EID: 3042731986     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357023835     Document Type: Article

References (23)

1. Bucolo, C., Maltese, A., Puglisi, G., Pignatello, R. (2002) Enhanced ocular anti-inflammatory activity of ibuprofen carried by a Eudragit RS100® nanoparticle suspension. Ophthalmic Res. 34: 319-323
2. Bucolo, C., Cuzzocrea, S., Mazzon, E., Caputi, A. P. (2003) Effects of cloricromene, a coumarin derivative, on endotoxin-induced uveitis in Lewis rats. Invest. Ophthalmol. Vis. Sci. 44: 1178-1184
3. Desai, S. D., Blanchard, J. (2000) Pluronic F127-based ocular delivery system containing biodegradable polyisobutylcyanoacrylate nanocapsules of pilocarpine. Drug Deliv. 7: 201-207
4. 2 formation in human platelets. Pharmacol. Res. Commun. 12: 329-337
5. Gupta, A. K., Madan, S., Majumdar, D. K., Maitra, A. (2000) Ketorolac entrapped in polymeric micelles: preparation, characterization and ocular anti-inflammatory studies. Int. J. Pharm. 19: 1-14
6. Kawakami, S., Nishida, K., Mukai, T., Yamamura, K., Nakamura, J., Sakaeda, T., Nakashima, M., Sakai, H. (2001) Controlled release and ocular absorption of tilisolol utilizing ophthalmic insert-incorporated lipophilic prodrugs. J. Control. Release 19: 255-263
7. Kawashima, Y. (2001) Nanoparticulate systems for improved drug delivery. Adv. Drug Deliv. Rev. 47: 1-2
8. Kawashima, Y., Niwa, T., Handa, T., Takeuchi, H., Iwamoto, T., Itoh, K. (1989) Preparation of controlled-release microspheres of ibuprofen with acrylic polymers by a novel quasi-emulsion solvent diffusion method. J. Pharm. Sci. 78: 68-72
9. Kotiyan, P. N., Vavia, P. R. (2001) Eudragits: role as crystallization inhibitors in drug-in-adhesive transdermal system of estradiol. Eur. J. Pharm. Biopharm. 52: 173-180
10. Le Bourlais, C., Acar, L., Zia, H., Sado, P. A., Needham, T., Leverge, R. (1998) Ophthalmic drug delivery systems - recent advances. Prog. Retin. Eye Res. 17: 33-58
11. Maltese, A., Bucolo, C. (2002) Simultaneous determination of cloricromene and its active metabolite in rabbit aqueous humor by high-performance liquid chromatography. J. Chromatogr. B 767: 153-158
12. McDonald, T. O., Shadduck, J. A. (1977) Eye irritation. In: Marzulli, F. M., Maibach, H. I. (eds) Advances in modern toxicology, vol. 4. Wiley & Sons, New York, pp. 139-191
13. Merodio, M., Irache, J. M., Valamesh, F., Mirshahi, M. (2002) Ocular disposition and tolerance of ganciclovir-loaded albumin nanoparticles after intravitreal injection in rats. Biomaterials 23: 1587-1594
14. Pignatello, R., Bucolo, C., Spedalieri, G., Maltese, A., Puglisi, G. (2002a) Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application. Biomaterials 23: 3247-3255
15. Pignatello, R., Bucolo, C., Ferrara, P., Maltese, A., Puleo, A., Puglisi G. (2002b) Eudragit RS100® nanosuspensions for the ophthalmic controlled delivery of ibuprofen. Eur. J. Pharm. Sci. 16: 53-61
16. Pignatello, R., Bucolo, C., Puglisi, G. (2002c) Ocular tolerability of Eudragit RS100 and RL100 nanosuspensions as carriers for ophthalmic controlled drug delivery. J. Pharm. Sci. 91: 2636-2641
17. Pignatello, R., Bucolo, C., Maltese, A., Maugeri, F., Puglisi G. (2004) Eudragit® RL100 nanosuspensions loaded with cloricromene for ophthalmic application: characterization and optimization of formulative parameters. Proceedings of the International Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 15-18 March 2004, Nuremberg, pp. 855-856
18. 2 activity in human platelets stimulated with thrombin. Agents Actions 29: 364-373
19. Rafiee-Tehram, M., Safari-Nikui, N., Peteriet, H., Beckett, T. (2001) Acrylic resins as rate-controlling membranes in novel formulation of a nine-day 17-beta-estradiol transdermal delivery system: in vitro and release modifier effect evaluation. Drug Dev. Ind. Pharm. 27: 431-437
20. Squadrito, F., Prosdocimi, M., Altavilla, D., Zingarelli, B., Caputi, A. (1991) Cloricromene. Cardiovasc. Drug Rev. 4: 357-371
21. Travagli, R. A., Zatta, A., Banzatto, N., Finesso, M., Marito, R., Tessari, F., Prasdocimi, M. (1989) Molecular aspects of cloricromene (AD6) distribution in human platelets and its pharmacological effects. Thromb. Res. 54: 327-338
22. Verma, P. R., Iyer, S. S. (2000) Transdermal delivery of propranolol using mixed grades of Eudragit: design and in vitro and in vivo evaluation. Drug Dev. Ind. Pharm. 26: 471-476
23. Willoughby, C. E., Batterbury, M., Kaye, S. B. (2002) Collagen corneal shields. Surv. Ophthalmol. 47: 174-182